Vance Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$574K Buy
624
+96
+18% +$97.3K 0.17% 67
2025
Q4
$568K Buy
528
+34
+7% +$32.5K 0.17% 66
2025
Q3
$377K Buy
494
+39
+9% +$29K 0.12% 82
2025
Q2
$355K Buy
455
+55
+14% +$42.7K 0.12% 82
2025
Q1
$331K Buy
400
+5
+1% +$4.16K 0.12% 80
2024
Q4
$305K Sell
395
-55
-12% -$45.5K 0.12% 76
2024
Q3
$399K Hold
450
0.15% 66
2024
Q2
$407K Buy
450
+51
+13% +$40.8K 0.17% 61
2024
Q1
$310K Buy
399
+33
+9% +$23.5K 0.12% 69
2023
Q4
$213K Sell
366
-38
-9% -$22.2K 0.09% 78
2023
Q3
$217K Buy
+404
New +$208K 0.1% 77

Other funds holding LLY

Vance Wealth's LLY Position: Q1 2026 in Review

Vance Wealth increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $97.3K and bringing the position to 624 shares worth $574K. The position accounts for 0.17% of the portfolio, ranked #67.

Vance Wealth first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vance Wealth held 624 shares of Eli Lilly worth $574K as of Q1 2026.
  • Vance Wealth bought 96 Eli Lilly shares in Q1 2026, an estimated $97.3K.
  • Eli Lilly made up 0.17% of Vance Wealth's portfolio in Q1 2026, its #67 holding.
  • Vance Wealth first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vance Wealth's 13F filing for Q1 2026, filed 15 May 2026.